vs
ICU MEDICAL INC（ICUI）与Liberty Energy Inc.（LBRT）财务数据对比。点击上方公司名可切换其他公司
Liberty Energy Inc.的季度营收约是ICU MEDICAL INC的1.9倍（$1.0B vs $540.7M），Liberty Energy Inc.净利率更高（2.2% vs -2.9%，领先5.1%），Liberty Energy Inc.同比增速更快（4.5% vs -14.1%），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -6.2%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
ICUI vs LBRT — 直观对比
营收规模更大
LBRT
是对方的1.9倍
$540.7M
营收增速更快
LBRT
高出18.6%
-14.1%
净利率更高
LBRT
高出5.1%
-2.9%
两年增速更快
ICUI
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $1.0B |
| 净利润 | $-15.7M | $22.6M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 2.2% |
| 净利率 | -2.9% | 2.2% |
| 营收同比 | -14.1% | 4.5% |
| 净利润同比 | 34.0% | — |
| 每股收益（稀释后） | $-0.63 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUILBRT
| Q1 26 | — | $1.0B | ||
| Q4 25 | $540.7M | $1.0B | ||
| Q3 25 | $537.0M | $947.4M | ||
| Q2 25 | $548.9M | $1.0B | ||
| Q1 25 | $604.7M | $977.5M | ||
| Q4 24 | $629.8M | $943.6M | ||
| Q3 24 | $589.1M | $1.1B | ||
| Q2 24 | $596.5M | $1.2B |
净利润ICUILBRT
| Q1 26 | — | $22.6M | ||
| Q4 25 | $-15.7M | $13.7M | ||
| Q3 25 | $-3.4M | $43.1M | ||
| Q2 25 | $35.3M | $71.0M | ||
| Q1 25 | $-15.5M | $20.1M | ||
| Q4 24 | $-23.8M | $51.9M | ||
| Q3 24 | $-33.0M | $73.8M | ||
| Q2 24 | $-21.4M | $108.4M |
毛利率ICUILBRT
| Q1 26 | — | — | ||
| Q4 25 | 37.5% | 20.6% | ||
| Q3 25 | 37.4% | 18.7% | ||
| Q2 25 | 37.9% | 22.1% | ||
| Q1 25 | 34.7% | 22.1% | ||
| Q4 24 | 36.1% | 21.4% | ||
| Q3 24 | 34.8% | 26.2% | ||
| Q2 24 | 34.8% | 27.9% |
营业利润率ICUILBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | 1.0% | 1.9% | ||
| Q3 25 | 2.6% | -0.3% | ||
| Q2 25 | 1.9% | 3.6% | ||
| Q1 25 | 2.1% | 1.9% | ||
| Q4 24 | 6.0% | 2.6% | ||
| Q3 24 | 1.4% | 9.4% | ||
| Q2 24 | 1.3% | 12.2% |
净利率ICUILBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | -2.9% | 1.3% | ||
| Q3 25 | -0.6% | 4.5% | ||
| Q2 25 | 6.4% | 6.8% | ||
| Q1 25 | -2.6% | 2.1% | ||
| Q4 24 | -3.8% | 5.5% | ||
| Q3 24 | -5.6% | 6.5% | ||
| Q2 24 | -3.6% | 9.3% |
每股收益（稀释后）ICUILBRT
| Q1 26 | — | $0.14 | ||
| Q4 25 | $-0.63 | $0.08 | ||
| Q3 25 | $-0.14 | $0.26 | ||
| Q2 25 | $1.43 | $0.43 | ||
| Q1 25 | $-0.63 | $0.12 | ||
| Q4 24 | $-0.97 | $0.31 | ||
| Q3 24 | $-1.35 | $0.44 | ||
| Q2 24 | $-0.88 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $699.1M |
| 总债务越低越好 | — | $7.1M |
| 股东权益账面价值 | $2.1B | $1.9B |
| 总资产 | $4.1B | $4.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ICUILBRT
| Q1 26 | — | $699.1M | ||
| Q4 25 | — | $27.6M | ||
| Q3 25 | — | $13.5M | ||
| Q2 25 | — | $19.6M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | $308.6M | $20.0M | ||
| Q3 24 | $312.5M | $23.0M | ||
| Q2 24 | $302.6M | $30.0M |
总债务ICUILBRT
| Q1 26 | — | $7.1M | ||
| Q4 25 | — | $246.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $190.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ICUILBRT
| Q1 26 | — | $1.9B | ||
| Q4 25 | $2.1B | $2.1B | ||
| Q3 25 | $2.1B | $2.1B | ||
| Q2 25 | $2.1B | $2.0B | ||
| Q1 25 | $2.0B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.0B | $1.9B |
总资产ICUILBRT
| Q1 26 | — | $4.4B | ||
| Q4 25 | $4.1B | $3.6B | ||
| Q3 25 | $4.1B | $3.5B | ||
| Q2 25 | $4.1B | $3.4B | ||
| Q1 25 | $4.2B | $3.4B | ||
| Q4 24 | $4.2B | $3.3B | ||
| Q3 24 | $4.3B | $3.3B | ||
| Q2 24 | $4.3B | $3.2B |
负债/权益比ICUILBRT
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | — |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | 13.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUILBRT
| Q1 26 | — | — | ||
| Q4 25 | $60.6M | $195.4M | ||
| Q3 25 | $56.7M | $51.5M | ||
| Q2 25 | $11.2M | $170.6M | ||
| Q1 25 | $51.3M | $192.1M | ||
| Q4 24 | $40.2M | $177.3M | ||
| Q3 24 | $36.1M | $244.5M | ||
| Q2 24 | $82.0M | $248.2M |
自由现金流ICUILBRT
| Q1 26 | — | — | ||
| Q4 25 | $36.0M | $-10.0M | ||
| Q3 25 | $27.6M | $-67.2M | ||
| Q2 25 | $-8.5M | $33.1M | ||
| Q1 25 | $36.7M | $58.2M | ||
| Q4 24 | $16.1M | $-26.2M | ||
| Q3 24 | $16.2M | $77.9M | ||
| Q2 24 | $62.5M | $112.2M |
自由现金流率ICUILBRT
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | -1.0% | ||
| Q3 25 | 5.1% | -7.1% | ||
| Q2 25 | -1.5% | 3.2% | ||
| Q1 25 | 6.1% | 6.0% | ||
| Q4 24 | 2.6% | -2.8% | ||
| Q3 24 | 2.7% | 6.8% | ||
| Q2 24 | 10.5% | 9.7% |
资本支出强度ICUILBRT
| Q1 26 | — | 13.1% | ||
| Q4 25 | 4.6% | 19.8% | ||
| Q3 25 | 5.4% | 12.5% | ||
| Q2 25 | 3.6% | 13.2% | ||
| Q1 25 | 2.4% | 13.7% | ||
| Q4 24 | 3.8% | 21.6% | ||
| Q3 24 | 3.4% | 14.6% | ||
| Q2 24 | 3.3% | 11.7% |
现金转化率ICUILBRT
| Q1 26 | — | — | ||
| Q4 25 | — | 14.28× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | 0.32× | 2.40× | ||
| Q1 25 | — | 9.55× | ||
| Q4 24 | — | 3.42× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | — | 2.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
LBRT
暂无分部数据
